These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 33407395

  • 1. A qualitative study to identify critical attributes and attribute-levels for a discrete choice experiment on oral pre-exposure prophylaxis (PrEP) delivery among young people in Cape Town and Johannesburg, South Africa.
    Dietrich JJ, Atujuna M, Tshabalala G, Hornschuh S, Mulaudzi M, Koh M, Ahmed N, Muhumuza R, Ssemata AS, Otwombe K, Bekker LG, Seeley J, Martinson NA, Terris-Prestholt F, Fox J.
    BMC Health Serv Res; 2021 Jan 06; 21(1):17. PubMed ID: 33407395
    [Abstract] [Full Text] [Related]

  • 2. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
    Dietrich JJ, Ahmed N, Tshabalala G, Wu M, Mulaudzi M, Hornschuh S, Atujuna M, Muhumuza R, Ssemata AS, Stranix-Chibanda L, Nematadzira T, Bekker LG, Martinson N, Seeley J, Fox J.
    PLoS One; 2023 Jan 06; 18(6):e0287627. PubMed ID: 37384792
    [Abstract] [Full Text] [Related]

  • 3. Experiences of oral pre-exposure prophylaxis use among heterosexual men accessing sexual and reproductive health services in South Africa: a qualitative study.
    Cholo FA, Dada S, Martin CE, Mullick S.
    J Int AIDS Soc; 2024 May 06; 27(5):e26249. PubMed ID: 38695102
    [Abstract] [Full Text] [Related]

  • 4. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment.
    Minnis AM, Atujuna M, Browne EN, Ndwayana S, Hartmann M, Sindelo S, Ngcwayi N, Boeri M, Mansfield C, Bekker LG, Montgomery ET.
    J Int AIDS Soc; 2020 Jun 06; 23(6):e25528. PubMed ID: 32544303
    [Abstract] [Full Text] [Related]

  • 5. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
    Amico KR, Wallace M, Bekker LG, Roux S, Atujuna M, Sebastian E, Dye BJ, Elharrar V, Grant RM.
    AIDS Behav; 2017 May 06; 21(5):1361-1375. PubMed ID: 27317411
    [Abstract] [Full Text] [Related]

  • 6. A multi-country cross-sectional study to assess predictors of daily versus on-demand oral pre-exposure prophylaxis in youth from South Africa, Uganda and Zimbabwe.
    Dietrich JJ, Ahmed N, Webb EL, Tshabalala G, Hornschuh S, Mulaudzi M, Atujuna M, Stranix-Chibanda L, Nematadzira T, Ssemata AS, Muhumuza R, Seeley J, Bekker LG, Weiss HA, Martinson N, Fox J, CHAPS team.
    J Int AIDS Soc; 2022 Aug 06; 25(8):e25975. PubMed ID: 36002910
    [Abstract] [Full Text] [Related]

  • 7. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
    Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, Coates TJ, Myer L, Joseph Davey DL.
    Int J STD AIDS; 2023 Jul 06; 34(8):548-556. PubMed ID: 36947792
    [Abstract] [Full Text] [Related]

  • 8. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries.
    Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, Tshabalala G, Nematadzira T, Hornschuh S, Nomvuyo M, Ahmed N, Maluadzi M, Anne Weiss H, Webb E, Stranix-Chibanda L, Janine Dietrich J, Seeley J, Fox J.
    PLoS One; 2023 Jul 06; 18(10):e0285132. PubMed ID: 37812644
    [Abstract] [Full Text] [Related]

  • 9. Perspectives of South African youth in the development of an implant for HIV prevention.
    Krogstad EA, Atujuna M, Montgomery ET, Minnis A, Ndwayana S, Malapane T, Shapley-Quinn MK, Manenzhe K, Bekker LG, van der Straten A.
    J Int AIDS Soc; 2018 Aug 06; 21(8):e25170. PubMed ID: 30152004
    [Abstract] [Full Text] [Related]

  • 10. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
    Poteat T, Malik M, van der Merwe LLA, Cloete A, Adams D, Nonyane BAS, Wirtz AL.
    Lancet HIV; 2020 Dec 06; 7(12):e825-e834. PubMed ID: 32622370
    [Abstract] [Full Text] [Related]

  • 11. Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa.
    Cheng CY, Quaife M, Eakle R, Cabrera Escobar MA, Vickerman P, Terris-Prestholt F.
    BMC Public Health; 2019 Jul 24; 19(1):996. PubMed ID: 31340785
    [Abstract] [Full Text] [Related]

  • 12. "Killing two birds with one stone" - a qualitative study on women's perspectives on the dual prevention pill in Johannesburg, South Africa.
    Tenza S, Mampuru L, Moji M, Zulu S, Begg L, Bruce IV, Reddy K, Friedland BA, Palanee-Phillips T, Mathur S.
    BMC Womens Health; 2024 Aug 22; 24(1):462. PubMed ID: 39174929
    [Abstract] [Full Text] [Related]

  • 13. Exploring adolescent girls and young women's PrEP-user profiles: qualitative insights into differentiated PrEP delivery platform selection and engagement in Cape Town, South Africa.
    Rousseau E, Sikkema KJ, Julies RF, Mazer K, O'Malley G, Heffron R, Morton JF, Johnson R, Celum C, Baeten JM, Bekker LG.
    J Int AIDS Soc; 2024 May 22; 27(5):e26254. PubMed ID: 38695101
    [Abstract] [Full Text] [Related]

  • 14. Factors that influence adolescent girls and young women's re-initiation or complete discontinuation from daily oral PrEP use: a qualitative study from Eastern Cape Province, South Africa.
    de Vos L, Mudzingwa EK, Fynn L, Atujuna M, Mugore M, Gandhi M, Celum C, Hosek S, Bekker LG, Daniels J, Medina-Marino A.
    J Int AIDS Soc; 2023 Sep 22; 26(9):e26175. PubMed ID: 37758649
    [Abstract] [Full Text] [Related]

  • 15. Perceived access to PrEP as a critical step in engagement: A qualitative analysis and discrete choice experiment among young men who have sex with men.
    Asiago-Reddy EA, McPeak J, Scarpa R, Braksmajer A, Ruszkowski N, McMahon J, London AS.
    PLoS One; 2022 Sep 22; 17(1):e0258530. PubMed ID: 35081116
    [Abstract] [Full Text] [Related]

  • 16. Preferences for Long-Acting PrEP Products Among Women and Girls: A Quantitative Survey and Discrete Choice Experiment in Eswatini, Kenya, and South Africa.
    Little KM, Hanif H, Anderson SM, Clark MR, Gustafson K, Doncel GF.
    AIDS Behav; 2024 Mar 22; 28(3):936-950. PubMed ID: 37971614
    [Abstract] [Full Text] [Related]

  • 17. Preferences for pre-exposure prophylaxis delivery via online pharmacy among potential users in Kenya: a discrete choice experiment.
    Saldarriaga EM, Chen Y, Montaño MA, Thuo N, Kiptinness C, Terris-Prestholt F, Stergachis A, Mugambi ML, Ngure K, Ortblad KF, Sharma M.
    J Int AIDS Soc; 2024 Oct 22; 27(10):e26356. PubMed ID: 39385266
    [Abstract] [Full Text] [Related]

  • 18. Preferences for Pre-exposure Prophylaxis Service Delivery Among Female Sex Workers in Malawi: A Discrete Choice Experiment.
    Lancaster KE, Lungu T, Bula A, Shea JM, Shoben A, Hosseinipour MC, Kohler RE, Hoffman IF, Go VF, Golin CE, Wheeler SB, Miller WC.
    AIDS Behav; 2020 May 22; 24(5):1294-1303. PubMed ID: 31720955
    [Abstract] [Full Text] [Related]

  • 19. Symptoms of post-traumatic stress and associations with sexual behaviour and PrEP preferences among young people in South Africa, Uganda and Zimbabwe.
    Webb EL, Dietrich JJ, Ssemata AS, Nematadzira TG, Hornschuh S, Kakande A, Tshabalala G, Muhumuza R, Mutonyi G, Atujuna M, Bere T, Bekker LG, Abas MA, Weiss HA, Seeley J, Stranix-Chibanda L, Fox J, CHAPS Study Team.
    BMC Infect Dis; 2022 May 16; 22(1):466. PubMed ID: 35578175
    [Abstract] [Full Text] [Related]

  • 20. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.
    Dubov A, Ogunbajo A, Altice FL, Fraenkel L.
    AIDS Care; 2019 May 16; 31(5):545-553. PubMed ID: 30554519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.